Cytokine Release Syndrome (CRS) - Baseline Assessment
Primary Audience:
This activity is intended to meet the educational needs of emergency department clinicians.
The following questions are designed to assess your knowledge and practice of patients with cytokine release syndrome.
Syed Abbas Ali, MBBS
Assistant Professor or Oncology
Department of Oncology, Hematologic Malignancies
Johns Hopkins School of Medicine
Baltimore, MD
Dr. Syed Abbas Ali is a medical oncology specialist in Baltimore, caring for patients with cancer.
Dr. Ali earned his M.B.B.S. at The Aga Khan University. He completed his residency at the University of Arkansas for Medical Sciences and performed a fellowship in medical oncology at the National Institutes of Health.
1.
Identify the common adverse events seen with bispecific antibodies and CAR T therapies that would present in the emergency department setting.
2.
Apply guideline recommendations and expert opinion to the identification of bispecific antibody and CAR T-cell therapy-related CRS in the emergency setting.
3.
Use practical approaches to CRS management in patients receiving bispecific antibodies and CAR T-cell therapies and establish open communication pathways with oncology experts.
